Evidence map›Paper›PMID 33281761›Full record

ArticleFrontiers in microbiology2020

D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.

Jianguang Lu, Hongjiang Xu, Jianghua Xia, Jie Ma, Jun Xu, Yanan Li, Jun Feng

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 232 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. The rise and future of peptide-based antimicrobials.Journal of microbiology (Seoul, Korea) · 2026
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jianguang LuKey State Laboratory of Drug Innovation and Pharmaceutical Technology, China State Institute of Pharmaceutical Industry, Shanghai, China.
Hongjiang XuKey State Laboratory of Drug Innovation and Pharmaceutical Technology, China State Institute of Pharmaceutical Industry, Shanghai, China.
Jianghua XiaKey State Laboratory of Drug Innovation and Pharmaceutical Technology, China State Institute of Pharmaceutical Industry, Shanghai, China.
Jie MaDepartment of Peptide Drugs R&D, Shanghai Duomirui Biotechnology Co., Ltd., Shanghai, China.
Jun XuDepartment of Peptide Drugs R&D, Shanghai Duomirui Biotechnology Co., Ltd., Shanghai, China.
Yanan LiKey State Laboratory of Drug Innovation and Pharmaceutical Technology, China State Institute of Pharmaceutical Industry, Shanghai, China.
Jun FengKey State Laboratory of Drug Innovation and Pharmaceutical Technology, China State Institute of Pharmaceutical Industry, Shanghai, China.
Shanghai Institute of Pharmaceutical Industry · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transition of antimicrobial peptides (AMPs) from the laboratory to market has been severely hindered by their instability toward proteases in biological systems. In the present study, we synthesized derivatives of the cationic AMP Pep05 (KRLFKKLLKYLRKF) by substituting L-amino acid residues with D- and unnatural amino acids, such as D-lysine, D-arginine, L-2,4-diaminobutanoic acid (Dab), L-2,3-diaminopropionic acid (Dap), L-homoarginine, 4-aminobutanoic acid (Aib), and L-thienylalanine, and evaluated their antimicrobial activities, toxicities, and stabilities toward trypsin, plasma proteases, and secreted bacterial proteases. In addition to measuring changes in the concentration of the intact peptides, LC-MS was used to identify the degradation products of the modified AMPs in the presence of trypsin and plasma proteases to determine degradation pathways and examine whether the amino acid substitutions afforded improved proteolytic resistance. The results revealed that both D- and unnatural amino acids enhanced the stabilities of the peptides toward proteases. The derivative DP06, in which all of the L-lysine and L-arginine residues were replaced by D-amino acids, displayed remarkable stability and mild toxicity

Indexed as

amino acid substitutionantimicrobial activityantimicrobial peptidesD-amino acidstabilitytoxicityunnatural amino acid

Identifiers

PMID33281761
PMCPMC7688903
OpenAlexW3101923829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.